We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Bone Cancer Drug Suits Try To Break Novartis

Law360 (June 26, 2007, 12:00 AM EDT) -- Drugs aimed at treating bone cancer and osteoporosis have suddenly become big business for plaintiffs attorneys, who continue to file suits against health care giants like Novartis Pharmaceutical Corp. alleging the medications have led to the painful deterioration of the jawbone.

Novartis is one of a slew of big-name drug makers that has found itself the target of a multidistrict product liability case in recent years, with a class of drugs known as bisphosphonates at the center of the gathering storm.

Over the past few years,...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.